Detalhe da pesquisa
1.
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Int J Gynecol Cancer
; 34(4): 627-630, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453176
2.
Novel Endocrine Therapeutic Opportunities for Estrogen Receptor-Positive Ovarian Cancer-What Can We Learn from Breast Cancer?
Cancers (Basel)
; 16(10)2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791941
3.
Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer.
Transl Oncol
; 37: 101769, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651891